Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study

Assessment of Retinal Photoreceptor Outer Segment Length With Optical Coherence Tomography Before and After Light Stimulation - a Pilot Study

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

It has been shown that reactions of human retinal photoreceptors to a light stimulus can be measured with custom-made, research prototype optical coherence tomography (OCT) systems. This can be used as a biomarker for the function of the photoreceptors. Due to the high technical demands on the system, however, the technique is currently not available for clinical purposes. In this pilot study a protocol to measure changes in retinal photoreceptor layer thickness before and after light stimulation shall be developed based on a commercial OCT system and newly developed algorithms. Other variables, such as circadian processes shall be investigated as well. After measurements in healthy volunteers, the protocol is planned to be applied in patients with primary open angle glaucoma (POAG) and age-related macular degeneration (AMD) to test for feasibility of the method in these patient groups.

Who May Be Eligible (Plain English)

Who May Qualify: - men and women aged over 18 years - signed willing to sign a consent form form - ametropia below 3 diopters - ability and willingness to follow instructions for healthy volunteers: - normal ophthalmologic findings for primary open angle glaucoma patients (POAG): - diagnosed POAG - MD \<= 10 dB for age-related macular degeneration (AMD): - diagnosed dry AMD - diagnosed stage II or stage III AMD Who Should NOT Join This Trial: - Presence of any abnormalities preventing reliable measurements - Ocular inflammation and ocular disease interfering with the study aims - Use of photosensitizing medication (phototoxic drugs, photoallergic drugs) in the 3 months preceding the study - Presence of any condition with the possibility of causing photosensitivity, including systemic lupus erythematosus SLE, Porphyria, Vitiligo, Xeroderma Pigmentosum and Albinism - Presence of any form of epilepsy - Ocular surgery in the 3 months preceding the study - Pregnancy, planned pregnancy or lactating - Any medical or surgical history, disorder or disease such as acute or chronic severe organic disease Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * men and women aged over 18 years * signed informed consent form * ametropia below 3 diopters * ability and willingness to follow instructions for healthy volunteers: * normal ophthalmologic findings for primary open angle glaucoma patients (POAG): * diagnosed POAG * MD \<= 10 dB for age-related macular degeneration (AMD): * diagnosed dry AMD * diagnosed stage II or stage III AMD Exclusion Criteria: * Presence of any abnormalities preventing reliable measurements * Ocular inflammation and ocular disease interfering with the study aims * Use of photosensitizing medication (phototoxic drugs, photoallergic drugs) in the 3 months preceding the study * Presence of any condition with the possibility of causing photosensitivity, including systemic lupus erythematosus SLE, Porphyria, Vitiligo, Xeroderma Pigmentosum and Albinism * Presence of any form of epilepsy * Ocular surgery in the 3 months preceding the study * Pregnancy, planned pregnancy or lactating * Any medical or surgical history, disorder or disease such as acute or chronic severe organic disease

Treatments Being Tested

OTHER

White light stimulation

Stimulation of the retina with white light

Locations (1)

Medical University of Vienna, Department of Clinical Pharmacology
Vienna, Vienna, Austria